Clinical trial
Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for…
NCT00004759 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00004759 |
|---|---|
| Title | Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury |
| Official title | Phase III Randomized, Double-Blind Study of Methylprednisolone by 24- Versus 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Collaborators | Yale University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Spinal Cord Injury |
| Intervention type | Drug |
| Interventions | methylprednisolone, tirilazad |
| Enrollment | 497 |
| Start date | Dec 1, 1991 |
| Primary completion | Aug 1, 2007 |
| First posted | Feb 25, 2000 |
| Last update posted | Sep 10, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: